Page last updated: 2024-08-24

capecitabine and Retroperitoneal Neoplasms

capecitabine has been researched along with Retroperitoneal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T	1

Other Studies

1 other study(ies) available for capecitabine and Retroperitoneal Neoplasms

Article	Year
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. European journal of endocrinology, 2012, Volume: 166, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Dacarbazine; Deoxycytidine; Drug Synergism; Fluorouracil; Humans; Immunohistochemistry; Male; Paraganglioma; Retroperitoneal Neoplasms; Succinate Dehydrogenase; Temozolomide; Treatment Outcome	2012

Article

Year

A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.

European journal of endocrinology, 2012, Volume: 166, Issue:6

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Dacarbazine; Deoxycytidine; Drug Synergism; Fluorouracil; Humans; Immunohistochemistry; Male; Paraganglioma; Retroperitoneal Neoplasms; Succinate Dehydrogenase; Temozolomide; Treatment Outcome

2012